MedAssessment

Sorry, but this listing is on a subscription plan which does not allow users to contact them via email

Sorry, but we don't have a location for this listing

Sorry, but we don't have a phone number for this listing

Sorry, but this listing is on a subscription plan which does not allow users to schedule meetings with them

Sorry, but this listing is on a subscription plan which does not allow users to view their website URL

Empowering Drug Safety: Excellence in Early Development and Pharmacovigilance

A leading authority in early development medical and drug safety assessments, this company excels in integrating the evolving safety profile into every aspect of the pharmacovigilance function. Renowned within the industry for its ability to connect compound-level insights with comprehensive safety strategies, the organization offers a unique blend of practical and efficient operations that surpasses standard provider services. By employing a "fix or fail fast" approach, the firm aims to ensure that drug sponsor management is empowered with high-quality data and strategic insights throughout the product lifecycle, from Phase 1 trials through to commercialization.

Specializing in providing access to a global safety database and offering full product lifecycle services, the company is adept at handling the intricacies of early drug development. Its approach is not limited to checking boxes but involves asking critical questions that delve deeper into the safety data story, ensuring that every piece of information is relevant and impactful. With commendations for its exceptional quality of clinical input and a minimal need for oversight, the company stands as a Drug Safety Center of Excellence. This allows for seamless management and delivery of safety functions, ultimately offering a significant advantage over other providers.

Empowering Drug Safety: Excellence in Early Development and Pharmacovigilance

A leading authority in early development medical and drug safety assessments, this company excels in integrating the evolving safety profile into every aspect of the pharmacovigilance function. Renowned within the industry for its ability to connect compound-level insights with comprehensive safety strategies, the organization offers a unique blend of practical and efficient operations that surpasses standard provider services. By employing a "fix or fail fast" approach, the firm aims to ensure that drug sponsor management is empowered with high-quality data and strategic insights throughout the product lifecycle, from Phase 1 trials through to commercialization.

Specializing in providing access to a global safety database and offering full product lifecycle services, the company is adept at handling the intricacies of early drug development. Its approach is not limited to checking boxes but involves asking critical questions that delve deeper into the safety data story, ensuring that every piece of information is relevant and impactful. With commendations for its exceptional quality of clinical input and a minimal need for oversight, the company stands as a Drug Safety Center of Excellence. This allows for seamless management and delivery of safety functions, ultimately offering a significant advantage over other providers.

Show More

Recommendations (0)

All (0)
Recommendations (0)
Reviews (0)
Videos (0)
No data found